Literature DB >> 8200616

On the relation of atrial natriuretic peptide and cyclic guanosine 3',5'-monophosphate plasma concentrations during ergometric exercise in healthy individuals.

G Jakob1, J Mair, B Puschendorf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8200616     DOI： 10.1055/s-2007-1000788

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN： 0018-5043            Impact factor:   2.936


× No keyword cloud information.
  3 in total

1.  Ergometric exercise testing and sensitivity of cyclic guanosine 3',5'-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction.

Authors:  G Jakob; J Mair; M Pichler; B Puschendorf
Journal:  Br Heart J       Date:  1995-02

2.  M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.

Authors:  Paul M McKie; Alessandro Cataliotti; Tomoko Ichiki; S Jeson Sangaralingham; Horng H Chen; John C Burnett
Journal:  J Am Heart Assoc       Date:  2014-01-02       Impact factor: 5.501

3.  Urinary cGMP predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus before exposure to contrast medium.

Authors:  Lyubov Chaykovska; Fabian Heunisch; Gina von Einem; Carl-Friedrich Hocher; Oleg Tsuprykov; Mira Pavkovic; Peter Sandner; Axel Kretschmer; Chang Chu; Saban Elitok; Johannes-Peter Stasch; Berthold Hocher
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.